Wang, Yingcong
Dong, Sanfeng
Hu, Ke
Xu, Li
Feng, Qilin
Li, Bo
Wang, Guangli
Chen, Gege
Zhang, Bibo
Jia, Xinyan
Xu, Zhijian
Gao, Xuejie
Zhang, Hui
Xie, Yongsheng
Lu, Meiling
Chang, Shuaikang
Song, Dongliang
Wu, Xiaosong
Jia, Qi
Zhu, Huabin
Zhou, Jinfeng
Zhu, Weiliang
Shi, Jumei https://orcid.org/0000-0002-8553-4559
Funding for this research was provided by:
National Natural Science Foundation of China (82300236, 82070224, 82170200, 82000220, 22077131, 81870158, 81971529)
Article History
Received: 21 September 2023
Accepted: 17 November 2023
First Online: 27 November 2023
Declarations
:
: All the human peripheral blood cells obtained were approved by the Review Board and Ethics Committee of Shanghai Tenth People’s Hospital (ID: SHSY-IEC-4.0/17-33/01). All study participants gave their informed consent to participate in the study. All the above procedures of mice experiments are approved by the Shanghai Science and Technology Commission (ID: SYXK 2011-0111).
: All authors give consent for the publication of the manuscript in Journal of Translational Medicine.
: The authors declare no conflict of interest.